2023. Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s293. DOI:https://doi.org/10.25251/skin.7.supp.293.